MRFF bias against musculoskeletal research funding

Clinicians managing conditions with a high disability burden such as musculoskeletal and respiratory diseases are unlikely to receive research funding from the government’s flagship $5 billion Medical Research Future Fund (MRFF), a new analysis shows. The MRFF is biased towards fatal diseases such as cancer and cardiovascular disease which receive disproportionate amount of research funding ...